Cargando…

COVID-19-related vaccines and therapeutics Preliminary insights on related patenting activity during the pandemic.

Detalles Bibliográficos
Autor principal: Staff, World Intellectual Property Organization
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Geneva : World Intellectual Property Organization, 2022.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mu 4500
001 EBOOKCENTRAL_on1348480949
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |||||||||||
008 221112s2022 sz o ||| 0 eng d
040 |a EBLCP  |b eng  |c EBLCP  |d OCLCO  |d OCLCQ  |d U3W  |d OCLCO  |d OCLCF  |d OCLCO 
020 |a 9789280533606 
020 |a 9280533606 
035 |a (OCoLC)1348480949 
082 0 4 |a 346.0486  |q OCoLC  |2 23/eng/20230216 
049 |a UAMI 
100 1 |a Staff, World Intellectual Property Organization. 
245 1 0 |a COVID-19-related vaccines and therapeutics  |h [electronic resource] :  |b Preliminary insights on related patenting activity during the pandemic. 
260 |a Geneva :  |b World Intellectual Property Organization,  |c 2022. 
300 |a 1 online resource (83 p.) 
500 |a Description based upon print version of record. 
505 0 |a Intro -- _Hlk93048502 -- Acknowledgements -- Key findings -- Introduction -- Background -- biology of COVID-19 -- Overview of patenting activity related to COVID-19 -- Patent filings during 2020-2021 -- Filing and publication of COVID-19-related patent applications over time -- COVID-19-related vaccine and therapeutic patent applicant profiles -- Research collaboration and IP strategies related to technologies important to COVID-19 vaccines and therapeutics -- Disclosure of sequences within patent documents -- COVID-19 vaccines -- Background -- vaccine platforms 
505 8 |a Conventional vaccine platforms -- Novel vaccine platforms -- Patent and vaccine distribution by vaccine platform and published applicant location -- Speed of vaccine development -- COVID-19 vaccine patent landscape -- Core vaccine technologies, collaboration and licensing -- Analysis of WHO data on COVID-19 vaccines -- Timelines on key technologies for COVID-19 vaccine development -- Technologies relevant to mRNA vaccine -- Timeline details for adenovirus vaccine development -- Timeline details for vaccine adjuvant development -- COVID-19 therapeutics -- Background 
505 8 |a Analysis of COVID-19 therapeutics-related patent applications by substances type -- Top locations of patent applicants for COVID-19 therapeutics and their filing strategies -- Highlights of patent filings related to COVID-19 therapeutic development -- Patent filings related to development of small-molecule drugs for COVID-19 -- Patent filings related to the development of biologics for COVID-19 -- Patents related to antibodies for COVID-19 treatment -- Peptide and protein therapies -- Nucleic-acid-based therapies -- Aptamer-mediated therapy -- Cell-based therapies 
505 8 |a Other biologic-based therapies -- Analysis of COVID-19 therapeutics in clinical trials -- Analysis of COVID-19 therapeutics data in the Milken Institute and Regulatory Affairs Professionals Society (RAPS) tracker data -- Distribution of COVID-19 drug candidates across small molecules and biologics, repurposed drugs and de novo synthesized drugs -- Classification of COVID-19 drug candidates in clinical trials by molecular nature and function -- Feature summary of examples of anti-COVID-19 drug candidates in clinical trials -- Perspectives -- Annex -- Data sources and methods 
505 8 |a Tables of vaccine types and candidates currently in clinical trials -- Examples of partial, early disclosure observed at the Israeli, U.K. and Singapore patent offices -- Glossary -- References -- Further reading 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a COVID-19 (Disease) 
650 0 |a Patents. 
650 0 |a Patents (International law) 
650 6 |a COVID-19. 
650 6 |a Brevets d'invention (Droit international) 
650 7 |a COVID-19 (Disease)  |2 fast 
650 7 |a Patents  |2 fast 
650 7 |a Patents (International law)  |2 fast 
776 0 8 |i Print version:  |a Staff, World Intellectual Property Organization  |t COVID-19-related vaccines and therapeutics  |d Geneva : World Intellectual Property Organization,c2022  |z 9789280533590 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=7113890  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL7113890 
994 |a 92  |b IZTAP